Find A Clinical Trial

Disease Type: Genitourinary

Trial ID IO102-IO103-022
Sponsor ID IO Biotech

A Phase 2 Multi Arm (Basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with Pembrolizumab as First-Line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, or Metastatic Urothelial Bladder Cancer

Trial ID FF10832-PEM-201
Sponsor ID KEYNOTE B-57

A Phase 2a Study with Safety Run-in to Evaluate the Safety, Tolerability, and Preliminary Efficacy of FF-10832 Monotherapy or in Combination with Pembrolizumab in Patients with Advanced Solid Tumors

Trial ID 18194
Sponsor ID STRO-002-GM1

A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an anti-Folate Receptor alpha (FolRá) Antibody Drug Conjugate (ADC), in Patients with Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers

Trial ID C2321001
Sponsor ID C2321001

A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF-06821497 IN THE TREATMENT OF ADULT PATIENTS WITH RELAPSED/REFRACTORY SMALL CELL LUNG CANCER (SCLC), CASTRATION RESISTANT PROSTATE CANCER (CRPC) AND FOLLICULAR LYMPHOMA (FL)